Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on April 30, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Notice of Intent for Monoclonal Antibodies and Plasmids Services for Malaria

Closed
NOI-NIAID-25-2260389Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541380
New
Joliet Job Corps-Request for Quote Asbestos Testing & Abatement
Solicitation # Joliet JCC Asbestos Testing & Abatement
Management & Training Corporation is seeking quotes for a fee-for-service subcontracting opportunity to provide asbestos testing and abatement services at the Joliet Job Corps in Joliet, Illinois. The scope of work includes sampling and laboratory analysis of ceiling tiles in the Administration Academic Building and Welcome Center, as well as testing and potential removal of asbestos-containing material from floor tiles in the Gymnasium, Warehouse, and Warehouse Storage Area, totaling approximately 4,200 square feet if confirmed. All work must be performed by licensed professionals using accredited laboratories and must comply with federal, State of Illinois, OSHA, and EPA regulations. Key deliverables include a sampling plan, waste shipment records, disposal manifests, and a final project completion report. This solicitation is open to various small business set-asides, including VOSB, SDVOSB, WOSB, and HUBZone small businesses, under NAICS code 541380. Bidders must submit a bid sheet, a completed supplier packet containing a W-9 and self-certification, proof of insurance, and three references for similar projects by October 21, 2026, at 3:00 PM CT. Award will be based on best value as determined by MTC. The contract is subject to Service Contract Labor Standards, specifically Wage Determination No. 2015-5019 Rev. 31, and includes various FAR clauses regarding small business utilization, minimum wages, and the protection of sensitive government information. Invoicing is to be submitted on a weekly or bi-weekly basis.
Joliet Job Corps

POSTED

about 14 hours ago

DEADLINE

in about 14 hours

General Info

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Piscataway, NJ, 08854, USA

Set-Aside

NONE

Documents

1

NOI-NIAID-25-2260389: Monoclonal Antibodies and Plasmid Services

PDF, Low prioritypresolicitation
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed
Posted

special-notice

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
PRE-SOLICITATION NOTICE NOI-NIAID-25-2260389 NAICS - 541380 This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Genscript USA, Inc of Piscataway, NJ to procure ongoing monoclonal antibodies and plasmid services for NIAID Laboratory of Immunogenetics (LIG). The National Institute of Allergy and Infectious Diseases (NIAID), Antibody Biology Unit (ABU) of the Laboratory of Immunogenetics (LIG), in furtherance of its mission to advance knowledge of human b cells and isolation of monoclonal antibodies requires a custom gene to antibodies, plasmid heavy chains, and plasmid light chain preparation. These custom antibody and plasmid services can be used to design new vaccine candidates against malaria. The ABU has used Genscript services for custom gene antibodies, plasmid heavy chains, and plasmid light chain preparation. This is a continuation of a master project that requires additional services. Continuity is paramount in order to retain integrity in the comparison of results. Delivery Location: Rockville, MD 20852 The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable consumables may submit a capability statement. All required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov by May 13, 2025 2:00 pm. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

in about 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS